Show simple item record

dc.contributor.authorOVALIOGLU, C
dc.contributor.authorAKTAS, E
dc.contributor.authorYAZIHAN, N
dc.contributor.authorBILIR, A
dc.contributor.authorERGUVEN, M
dc.contributor.authorDundar, TOLGA TURAN
dc.contributor.authorKORKMAZ, SAYİME
dc.contributor.authorSEYITHANOGLU, H
dc.date.accessioned2019-10-05T21:03:22Z
dc.date.available2019-10-05T21:03:22Z
dc.date.issued2012-01-01
dc.identifier10.1002/clc.20258
dc.identifier.urihttps://hdl.handle.net/20.500.12645/6403
dc.language.isoen
dc.subjectERGUVEN M., BILIR A., YAZIHAN N., KORKMAZ S., AKTAS E., OVALIOGLU C., Dundar T. T. , SEYITHANOGLU H., -Imatinib mesylate decreases the cytotoxic effect of roscovitine on human glioblastoma cells in vitro and the role of midkine.-, Oncology letters, cilt.3, ss.200-208, 2012
dc.titleImatinib mesylate decreases the cytotoxic effect of roscovitine on human glioblastoma cells in vitro and the role of midkine.
dc.typeArticle
local.avesis.response6279
local.article.journalnameClinical cardiology
dc.identifier.wosWOS:000298124700037
dc.identifier.scopus84855236250
dc.identifier.doi10.3892/ol.2011.434
dc.identifier.pubmed22740881
local.publication.isinternational1


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record